BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16997739)

  • 1. Alveolar macrophages as orchestrators of COPD.
    Barnes PJ
    COPD; 2004 Apr; 1(1):59-70. PubMed ID: 16997739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar macrophages in chronic obstructive pulmonary disease (COPD).
    Barnes PJ
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL627-37. PubMed ID: 15579256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2.
    Traves SL; Smith SJ; Barnes PJ; Donnelly LE
    J Leukoc Biol; 2004 Aug; 76(2):441-50. PubMed ID: 15155777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J; Hag H; Jungck D; Urban K; Koch A
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids: the drugs to beat.
    Barnes PJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators of chronic obstructive pulmonary disease.
    Barnes PJ
    Pharmacol Rev; 2004 Dec; 56(4):515-48. PubMed ID: 15602009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The missing link: chemokine receptors and tissue matrix breakdown in COPD.
    Smit JJ; Lukacs NW
    Trends Pharmacol Sci; 2006 Nov; 27(11):555-7. PubMed ID: 17000010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function.
    Poliska S; Csanky E; Szanto A; Szatmari I; Mesko B; Szeles L; Dezso B; Scholtz B; Podani J; Kilty I; Takacs L; Nagy L
    Respiration; 2011; 81(6):499-510. PubMed ID: 21430361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease.
    Berenson CS; Garlipp MA; Grove LJ; Maloney J; Sethi S
    J Infect Dis; 2006 Nov; 194(10):1375-84. PubMed ID: 17054066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.
    Culpitt SV; Rogers DF; Fenwick PS; Shah P; De Matos C; Russell RE; Barnes PJ; Donnelly LE
    Thorax; 2003 Nov; 58(11):942-6. PubMed ID: 14586044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Na(+)/Ca(2+) exchange blocker, Benzamil, on alveolar macrophage function in patients with chronic obstructive pulmonary disease].
    Li X; Wang LX; Zhang JP; Gu OX; Song MJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):522-4. PubMed ID: 17767818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPD: current therapeutic interventions and future approaches.
    Barnes PJ; Stockley RA
    Eur Respir J; 2005 Jun; 25(6):1084-106. PubMed ID: 15929966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPD: is there light at the end of the tunnel?
    Barnes PJ
    Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro modeling of human alveolar macrophage smoke exposure: enhanced inflammation and impaired function.
    Winkler AR; Nocka KH; Sulahian TH; Kobzik L; Williams CM
    Exp Lung Res; 2008 Nov; 34(9):599-629. PubMed ID: 19005923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HDAC2 in the pathophysiology of COPD.
    Barnes PJ
    Annu Rev Physiol; 2009; 71():451-64. PubMed ID: 18817512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production.
    Winkler AR; Nocka KN; Williams CM
    Pulm Pharmacol Ther; 2012 Aug; 25(4):286-92. PubMed ID: 22613758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced anti-inflammation of inhaled dexamethasone palmitate using mannosylated liposomes in an endotoxin-induced lung inflammation model.
    Wijagkanalan W; Higuchi Y; Kawakami S; Teshima M; Sasaki H; Hashida M
    Mol Pharmacol; 2008 Nov; 74(5):1183-92. PubMed ID: 18669445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E1A has no effect on LPS-induced IL-6 secretion in rat alveolar epithelial cells.
    Chen J; Luo J; Li B; Ran P
    Respiration; 2009; 78(1):84-92. PubMed ID: 19299891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.